Drug Shortage Report for APO-QUETIAPINE XR
Report ID | 74033 |
Drug Identification Number | 02457229 |
Brand name | APO-QUETIAPINE XR |
Common or Proper name | QUETIAPINE XR |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 BTL |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-01-28 |
Estimated end date | 2020-11-08 |
Actual end date | 2020-11-02 |
Shortage status | Resolved |
Updated date | 2020-11-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2020-10-23 | English | Compare |
v22 | 2020-10-23 | French | Compare |
v23 | 2020-11-03 | English | Compare |
v24 | 2020-11-03 | French | Compare |